According to the Zhitong Finance App, Ricoh Biotech (02179) announced its 2026 interim results, with revenue of about 47,000 yuan, a year-on-year decrease of 99.57%; loss attributable to parent company owners was about 212 million yuan, a year-on-year decrease of 37.82%; and a loss of 0.34 yuan per share.

According to the announcement, the decrease in revenue was mainly due to revenue of 10.8 million yuan generated from the granting of intellectual property licenses in the previous period. Similar licensing business was underway during the reporting period, but the revenue recognition conditions have not yet been met.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.